Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia

T. P. Kazubskaya; Казубская Т. П.; V. I. Loginov; Логинов В. И.; D. S. Khodyrev; Ходырев Д. С.; V. D. Ermilova; Ермилова В. Д.; Yu. G. Payanidi; Паяниди Ю. Г.; N. V. Chkhikvadze; Чхиквадзе Н. В.; V. Yu. Selchuk; Сельчук В. Ю.; E. A. Braga; Брага Э. А.

doi:10.17650/1994-4098-2012-0-1-61-68

Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia

Authors: Kazubskaya T.P.¹, Loginov V.I.², Khodyrev D.S.², Ermilova V.D.¹, Payanidi Y.G.¹, Chkhikvadze N.V.¹, Selchuk V.Y.¹, Braga E.A.²
Affiliations:
1. N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
2. State Research Center, State Research Institute of Genetics, Moscow
Issue: No 1 (2012)
Pages: 61-68
Section: GYNECOLOGY. DIAGNOSIS
Published: 23.02.2012
URL: https://ojrs.abvpress.ru/ojrs/article/view/81
DOI: https://doi.org/10.17650/1994-4098-2012-0-1-61-68
ID: 81

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

The methylation status of the tumor suppressor genes RASSF1A, RARβ2, and SEMA3B was studied in the samples of cancer and its histologically normal tissue of the breast and ovaries. The high rate of abnormal methylation of the CpG islet in the RASSF1A, RARβ2, and SEMA3B genes was found in the tumors of the breast (78% (32/41), 46% (26/56), and 35% (22/65), respectively) and ovaries 73% (33/45), 30% (15/50), and 50% (25/51). Hypermethylation in the CpG islets belonging to the RASSF1A and RARβ2 genes was first ascertained in 90% of the patients with polyneoplasms involving the breast and ovaries. Abnormal methylation of the promotor region of the RASSF1A gene was shown to be detectable in preclinical-stage and anaplasia-degree breast and ovarian cancer. There was a correlation of the rate of methylation in the promoter regions of the RARβ2 and SEMA3B genes with clinical-stage and anaplasia-degree breast and ovarian cancer. Analysis of gene methylation in biological fluids provides considerable opportunity to use methylation of DNA as a marker in clinical practice.

Keywords

breast cancer, ovarian cancer, polyneoplasia, methylation, RASSF1A, RARβ2, and SEMA3B genes

References

Supplementary files

Supplementary Files

Action

1. JATS XML

Download

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia

Full Text

Abstract

Keywords

About the authors

References

Supplementary files